Ppointment of Dr Surinder 'Dass' Chahal, formerly a senior Croda VP, as Cosmetic Science / Customer Alliances Advisor to the Board, Simon Hewitson as COO and Emily Bertram as Group Finance Director
o Croda studies completed and commercial agreement finalised
o Zenakine™ (SkinBiotix®) launched to the global cosmetics industry in April 2025 and first tranche of royalty income recognised in total Group revenue
· AxisBiotix™
o Ongoing direct sales growth and continued strong customer retention
o Development of second AxisBiotix™ line for blemish-prone skin
o Exclusive 2 year commercial agreement signed with Superdrug Stores plc
o Post year end, both AxisBiotix™ lines launched in >180 High Street stores